EU PHARMACEUTICAL LEGISLATION
In order to ensure regular access to plasma medicines for those in need, it is critical that policymakers acknowledge the clinical urgency for increased plasma collection in Europe. Discover the latest updates on legislation surrounding the broader European plasma donation ecosystem.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
PPTA position paper on the importance of the EU-US MRA for patient access to plasma-derived medicinal products (PDMPs)
All
This is some text inside of a div block.
This is some text inside of a div block.
PPTA position paper on the importance of the EU-US MRA for patient access to plasma-derived medicinal products (PDMPs)
All
EU pharmaceutical legislation
This is some text inside of a div block.
PPTA position paper on the revision of the general EU pharmaceutical legislation - English
PPTA position paper on the evaluation of the EU pharmaceutical legislation
All
This is some text inside of a div block.
This is some text inside of a div block.
PPTA position paper on the revision of the general EU pharmaceutical legislation - English
PPTA position paper on the evaluation of the EU pharmaceutical legislation
All
EU pharmaceutical legislation
This is some text inside of a div block.